Profound Medical Corp. (PROF) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$16.1M

Net Income/Loss (FY2025)

-$42.6M

Total Assets (FY2025)

$77.5M

Total Equity (FY2025)

$66.4M

Cash Flows from Operating Activities (FY2025)

-$38.2M

Source: Profound Medical Corp. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.